Methotrexate is an antimetabolite and antifolate drug used in oncology to treat various cancers, including leukemia and lymphoma, as well as autoimmune conditions such as rheumatoid arthritis and psoriasis.… Read more


















![Chemical structure of 4-[[(2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoic Acid Methyl Ester](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F34794-87-1-4-2-Amino-14-dihydro-4-oxo-6-pteridinylmethylaminobenzoic-Acid-Methyl-Ester.png&w=3840&q=75)































Methotrexate is an antimetabolite and antifolate drug used in oncology to treat various cancers, including leukemia and lymphoma, as well as autoimmune conditions such as rheumatoid arthritis and psoriasis. By inhibiting the enzyme dihydrofolate reductase, it interferes with nucleotide synthesis and inhibits cellular replication. This category provides essential reference standards for the parent drug, its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. These materials are fundamental for pharmaceutical laboratories to conduct accurate impurity profiling, rigorous method validation, and ongoing quality control. By serving as a reliable benchmark for analytical testing, these standards support compliance with regulatory guidelines and help ensure the stability and characterization of pharmaceutical products. Each compound facilitates precise identification and quantification in complex matrices, which is critical for consistent drug development and the maintenance of reliable analytical results throughout the manufacturing lifecycle.